← FDA Drug Approvals (Drugs@FDA)

DEFENCATH

NDA · New Drug Application · Sponsor: CORMEDIX · Approved 2023-11-15

Drug application

FDA Application #

NDA214520

Application type

New Drug Application

Brand name

DEFENCATH

Generic name

TAUROLIDINE AND HEPARIN

Active ingredients

HEPARIN SODIUM; TAUROLIDINE

Dosage form

SOLUTION

Route

N/A

Marketing status

Prescription

Sponsor

CORMEDIX

Manufacturer

CorMedix Inc.

First approval

2023-11-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown